![]() |
2nd National Conference Human Retroviruses and Related InfectionsWashington, DC - January 29 - February 2, 1995 |
Natl Conf Hum Retrovir Relat Infect 1995 Jan 29-Feb 2;2: (abstract no. 22)
Meylan PR1,2, Burgisser P3, Weyrich SC2, and Spertini F3
1Institute of Microbiology, 2Divisions of Infectious Diseases and of Immunology and 3Allergology, CHIV, Lausanne, Switzerland
25 HIV-1 patients (CD4+ T cell range: 4 to 760/µl, median 362) were selected for study of lymph node cells (LNC), obtained by fine needle aspiration (FNA) and PBMC obtained simultaneously. LN aspiration was performed on 21 patients who had accessible LN. LNC, ranging from 6×103 to 2×106 (median 6×105) were obtained in 17/21 subjects. Immunophenotype could be determined by flow cytometry in 9 patients. Mean % of CD4+CD3+T cells in LNC and PBMC was 23.2 and 14.6. Mean % of CD8+CD3+T cells in LNC and PBMC was 23.1 and 45.0 respectively. CD4+/CD8+ ratios were much higher in LNC (mean/SD: 1.06±0.31) than in PBMC (0.35±0.13). The amount of HIV DNA (11 patients) and RNA (8 patients) was determined in the plasma, LNC and PBMC by competitive (RT)- PCR. The number of copies of viral DNA/105 cells was higher in LNC than in PBMC (LNC/PBMC ratio range: 0.54 to 25, median: 3.4). The number of copies of unspliced viral RNA/105 cells was much higher in LNC than in PBMC (LNC/PBMC ratio range: 65 to 1159, median: 435). A semi-quantitative coculture assay with lymphoblasts from healthy donors was used to assess the infectivity of LNC compared to PBMC in 14 patients. The minimum number of LNC necessary to cause a positive coculture ranged from 103 to >105 (median 104) while the corresponding number for PBMC ranged from 103 to >106 (median: 5×105). In patients selected for palpable LN, LNC could be obtained by FNA in a majority of patients. This methodology should allow to monitor the effect of antiviral therapy on the viral load in the lymphoid tissue in a non invasive manner.
Keywords: AIDS Vaccines, Acquired Immunodeficiency Syndrome, Anti-HIV Agents, Antigens, CD4, Antigens, CD8, CD4-Positive T-Lymphocytes, DNA, Viral, HIV, HIV Infections, HIV Seropositivity, HIV Seroprevalence, HIV-1, Humans, Immunophenotyping, Lymph Nodes, RNA, Viral, Viral Load, immunology, organization & administration
1995-01-29
22
Copyright © 1995 - The American Society for Microbiology. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the American Society for Microbiology.